Editas Medicine Names Charles Albright as Chief Scientific Officer
August 22, 2016 07:30 ET
|
Editas Medicine
CAMBRIDGE, Mass., Aug. 22, 2016 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, announced today the appointment of Charles Albright, Ph.D. as Chief...